pubmed-article:10356084 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10356084 | lifeskim:mentions | umls-concept:C0008865 | lld:lifeskim |
pubmed-article:10356084 | lifeskim:mentions | umls-concept:C0008377 | lld:lifeskim |
pubmed-article:10356084 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
pubmed-article:10356084 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
pubmed-article:10356084 | lifeskim:mentions | umls-concept:C0205054 | lld:lifeskim |
pubmed-article:10356084 | lifeskim:mentions | umls-concept:C0001374 | lld:lifeskim |
pubmed-article:10356084 | lifeskim:mentions | umls-concept:C0030016 | lld:lifeskim |
pubmed-article:10356084 | lifeskim:mentions | umls-concept:C0040676 | lld:lifeskim |
pubmed-article:10356084 | lifeskim:mentions | umls-concept:C0439962 | lld:lifeskim |
pubmed-article:10356084 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
pubmed-article:10356084 | lifeskim:mentions | umls-concept:C0441994 | lld:lifeskim |
pubmed-article:10356084 | lifeskim:mentions | umls-concept:C0005492 | lld:lifeskim |
pubmed-article:10356084 | lifeskim:mentions | umls-concept:C2828366 | lld:lifeskim |
pubmed-article:10356084 | lifeskim:mentions | umls-concept:C1705851 | lld:lifeskim |
pubmed-article:10356084 | lifeskim:mentions | umls-concept:C1555707 | lld:lifeskim |
pubmed-article:10356084 | lifeskim:mentions | umls-concept:C2752151 | lld:lifeskim |
pubmed-article:10356084 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:10356084 | pubmed:dateCreated | 1999-6-24 | lld:pubmed |
pubmed-article:10356084 | pubmed:abstractText | The cholesterol-lowering effects of tangerine peel extract and a mixture of two citrus flavonoids were tested. Male rats were fed a 1 g/100 g high-cholesterol diet for 42 d with supplements of either tangerine-peel extract or a mixture of naringin and hesperidin (0.5 g/100 g) to study the effects of plasma and hepatic lipids, hepatic enzyme activities, and the excretion of fecal neutral sterols. Both the tangerine-peel extract and mixture of two flavonoids significantly lowered the levels (mean +/- SE) of plasma (2.44 +/- 0. 59 and 2.42 +/- 0.31 mmol/L, vs. 3.80 +/- 0.28 mmol/L, P < 0.05), hepatic cholesterol (0.143 +/- 0.017 and 0.131 +/- 0.010 mmol/g vs. 0.181 +/- 0.003 mmol/g, P < 0.05), and hepatic triglycerides (0.069 +/- 0.007 and 0.075 +/- 0.006 mmol/g vs. 0.095 +/- 0.002 mmol/g, P < 0.05) compared to those of the control. The 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase (1565.0 +/- 106. 0 pmol. min-1. mg protein-1 and 1783.0 +/- 282 pmol. min-1. mg protein-1 vs. 2487.0 +/- 210.0 pmol. min-1. mg protein-1, P < 0.05) and acyl CoA: cholesterol O-acyltransferase (ACAT) activities (548.0 +/- 65.0 and 615.0 +/- 80.0 pmol. min-1. mg protein-1 vs. 806.0 +/- 105.0 pmol. min-1. mg protein-1, P < 0.05) were significantly lower in the experimental groups than in the control. These supplements also substantially reduced the excretion of fecal neutral sterols compared to the control (211.1 +/- 26.7 and 208.2 +/- 31.6 mg/d vs. 521.9 +/- 53.9 mg/d). The inhibition of HMG-CoA reductase and ACAT activities resulting from the supplementation of either tangerine-peel extract or a combination of its bioflavonoids could account for the decrease in fecal neutral sterol that appears to compensate for the decreased cholesterol biosynthesis in the liver. | lld:pubmed |
pubmed-article:10356084 | pubmed:language | eng | lld:pubmed |
pubmed-article:10356084 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10356084 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10356084 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10356084 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10356084 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10356084 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10356084 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10356084 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10356084 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10356084 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10356084 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10356084 | pubmed:month | Jun | lld:pubmed |
pubmed-article:10356084 | pubmed:issn | 0022-3166 | lld:pubmed |
pubmed-article:10356084 | pubmed:author | pubmed-author:LeeS HSH | lld:pubmed |
pubmed-article:10356084 | pubmed:author | pubmed-author:BokS HSH | lld:pubmed |
pubmed-article:10356084 | pubmed:author | pubmed-author:BaiK TKT | lld:pubmed |
pubmed-article:10356084 | pubmed:author | pubmed-author:ChoiM SMS | lld:pubmed |
pubmed-article:10356084 | pubmed:author | pubmed-author:ParkY BYB | lld:pubmed |
pubmed-article:10356084 | pubmed:author | pubmed-author:SonK HKH | lld:pubmed |
pubmed-article:10356084 | pubmed:author | pubmed-author:JeongT STS | lld:pubmed |
pubmed-article:10356084 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10356084 | pubmed:volume | 129 | lld:pubmed |
pubmed-article:10356084 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10356084 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10356084 | pubmed:pagination | 1182-5 | lld:pubmed |
pubmed-article:10356084 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:10356084 | pubmed:meshHeading | pubmed-meshheading:10356084... | lld:pubmed |
pubmed-article:10356084 | pubmed:meshHeading | pubmed-meshheading:10356084... | lld:pubmed |
pubmed-article:10356084 | pubmed:meshHeading | pubmed-meshheading:10356084... | lld:pubmed |
pubmed-article:10356084 | pubmed:meshHeading | pubmed-meshheading:10356084... | lld:pubmed |
pubmed-article:10356084 | pubmed:meshHeading | pubmed-meshheading:10356084... | lld:pubmed |
pubmed-article:10356084 | pubmed:meshHeading | pubmed-meshheading:10356084... | lld:pubmed |
pubmed-article:10356084 | pubmed:meshHeading | pubmed-meshheading:10356084... | lld:pubmed |
pubmed-article:10356084 | pubmed:meshHeading | pubmed-meshheading:10356084... | lld:pubmed |
pubmed-article:10356084 | pubmed:meshHeading | pubmed-meshheading:10356084... | lld:pubmed |
pubmed-article:10356084 | pubmed:meshHeading | pubmed-meshheading:10356084... | lld:pubmed |
pubmed-article:10356084 | pubmed:meshHeading | pubmed-meshheading:10356084... | lld:pubmed |
pubmed-article:10356084 | pubmed:meshHeading | pubmed-meshheading:10356084... | lld:pubmed |
pubmed-article:10356084 | pubmed:meshHeading | pubmed-meshheading:10356084... | lld:pubmed |
pubmed-article:10356084 | pubmed:meshHeading | pubmed-meshheading:10356084... | lld:pubmed |
pubmed-article:10356084 | pubmed:meshHeading | pubmed-meshheading:10356084... | lld:pubmed |
pubmed-article:10356084 | pubmed:meshHeading | pubmed-meshheading:10356084... | lld:pubmed |
pubmed-article:10356084 | pubmed:year | 1999 | lld:pubmed |
pubmed-article:10356084 | pubmed:articleTitle | Plasma and hepatic cholesterol and hepatic activities of 3-hydroxy-3-methyl-glutaryl-CoA reductase and acyl CoA: cholesterol transferase are lower in rats fed citrus peel extract or a mixture of citrus bioflavonoids. | lld:pubmed |
pubmed-article:10356084 | pubmed:affiliation | Korea Institute of Bioscience and Biotechnology, KIST, Yusong, Taejon, 305-333, Korea. | lld:pubmed |
pubmed-article:10356084 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10356084 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10356084 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10356084 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10356084 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10356084 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10356084 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10356084 | lld:pubmed |